A new word in the treatment of breast cancer
The results of clinical studies conducted in London indicate the effectiveness of a new drug Anastrozole in relation to the treatment of breast cancer.
The research involved nearly 3,000 women. All had a diagnosis of ductal carcinoma. After surgical treatment of 5 years had taken drugs. The first group of traditional Tamoxifen, Anastrozole second. Analysis of the results of observations showed that among the participants of the second group, the recurrence rate was less than 11%.
However, this difference in the frequency of recurrent disease scientists believe is not very substantial. They drew attention to the other effects from taking Anastrozole. On the one hand, a more rare diagnosis of cancer of the uterus and ovaries, deep vein thrombosis, on the other, more frequent heart attacks and skeletal and muscular disorders.
Thus, Tamoxifen and Anastrozole can be considered effective against the breast tumors, and because of the difference side effects, you can choose a more suitable directly in each case.